The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
| Autor: | D Black, I. R. Reid, J. A. Cauley, S Boonen, F Cosman, P C Leung, P Lakatos, Z Man, S. R. Cummings, T. F. Hue, M. E. Ruzycky, R Martinez, G Su, C Bucci-Rechtweg, R Eastell |
|---|---|
| Jazyk: | English<br />Russian |
| Rok vydání: | 2011 |
| Předmět: | |
| Zdroj: | Остеопороз и остеопатии, Vol 14, Iss 1, Pp 37-37 (2011) |
| Druh dokumentu: | article |
| ISSN: | 2072-2680 2311-0716 |
| DOI: | 10.14341/osteo2011137-37 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|